Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3046861	-legi-o	— (—)	211	230	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Pneumonia, organism unspecified

163

81.81

222.93

1.1

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

161

72.21

208.85

1.1

1.0

—

All pneumoniae

161

71.88

207.88

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

158

59.99

203.16

1.1

1.0

—

Influenza and pneumonia

153

69.61

188.11

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

144

79.43

171.61

1.1

1.0

—

144

79.43

171.61

1.1

1.0

—

COPD/asthma/ILD related infections

38.73

77.91

1.1

1.0

—

COPD/asthma related infections

38.73

77.91

1.1

1.0

—

Other respiratory diseases principally affecting the interstitium

18.18

69.81

1.1

1.0

—

Bacterial pneumoniae

36.13

65.11

1.2

1.0

—

Other interstitial pulmonary diseases

18.65

63.03

1.1

1.0

—

Interstitial lung disease

18.65

63.03

1.1

1.0

—

Interstitial lung disease endpoints

18.65

63.03

1.1

1.0

—

ILD, hospital admissions

18.28

61.19

1.1

1.0

—

Bacterial infection, other or unspecified

7.72

48.15

1.1

—

Bacterial infection, other or unspecified

7.98

46.58

1.1

—

Fever of other and unknown origin

7.95

46.32

1.1

—

Bacterial pneumonia (organism specified)

8.41

45.87

1.1

—

ILD, hospital admissions 1, main diag only

15.70

45.15

1.1

1.0

—

Other bacterial diseases

104

5.37

36.19

1.1

1.0

—

Oral corticosteroids

106

5.04

34.84

1.1

—

Other bacterial diseases

5.30

34.02

1.1

—

ILD medications: immunosuppressive drugs

6.39

32.57

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

5.00

31.03

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

34.86

30.84

1.1

1.0

—

Other pulmonary diagnosis

19.55

30.59

1.0

—

Asthma

19.41

29.99

1.2

1.0

—

Implicit bacterial Sepsis

6.59

29.29

1.1

—

Covid-19 confirmed case

6.83

29.19

1.2

1.1

—

Excluding asthma or asthma-COPD overlap

18.54

28.55

1.0

—

Bacterial Sepsis

6.01

28.11

1.1

—

Implicit bacterial Sepsis

6.04

27.81

1.1

—

Other septicaemia

7.10

27.76

1.1

1.0

—

Asthma (only as main-diagnosis)

18.53

27.51

1.1

1.0

—

Septicaemia

6.59

27.50

1.2

1.0

—

COPD differential diagnosis

17.54

26.52

1.0

—

ILD differential diagnosis

17.54

26.52

1.0

—

Asthma-related pneumonia

6.00

25.78

1.2

1.1

—

Asthma, hospital admissions 3, pneumonia

6.00

25.77

1.2

1.1

—

Asthma-related pneumonia or sepsis

6.00

25.77

1.2

1.1

—

Inflammatory bowel disease treatment related agents

106

4.22

24.99

1.0

1.1

—

Implicit Sepsis

103

4.62

24.59

1.1

—

Asthma (mode)

16.61

24.21

1.1

1.0

—

First line medication for Crohn's disease

4.63

24.21

1.1

—

Explicit Sepsis

5.69

23.84

1.2

1.1

—

ILD medications

4.32

23.41

1.1

—

Renal tubulo-interstitial diseases

121

4.13

22.76

1.1

—

Implicit Sepsis

109

4.29

22.69

1.1

—

Bacterial pneumonia, not elsewhere classified

25.65

22.47

1.2

1.0

—

Codes for special purposes

5.00

22.19

1.2

1.0

—

Provisional assignment of new diseases of uncertain etiology

5.00

22.19

1.2

1.0

—

Asthma, unspecified (mode), excluding more controls

43.42

21.75

1.2

1.0

—

Acute renal failure

7.71

21.65

1.1

1.0

—

Asthma, excluding more controls

35.50

21.59

1.2

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

7.13

21.58

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

36.65

21.17

1.1

1.0

—

Second line medication for Crohn's disease

4.65

19.99

1.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

132

3.66

19.82

1.1

—

Asthma, unspecified (mode)

22.61

19.53

1.2

1.0

—

Renal failure

4.47

19.15

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

110

3.92

19.08

1.1

—

L04AX Other immunosuppressants

4.55

19.06

1.0

1.1

—

COPD (mode)

22.03

18.36

1.2

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

109

3.80

17.90

1.1

—

All kidney diseases

126

3.47

16.84

1.1

—

All chronic kidney diseases

4.23

16.39

1.0

—

Heart failure, not strict

3.78

16.23

1.2

1.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

5.20

15.93

1.2

1.1

—

Asthma, hospital admission 2, infections

112

3.94

15.78

1.2

1.1

—

Asthma-related infections

112

3.94

15.78

1.2

1.1

—

Diagnoses used for exclusion with ILD

5.84

15.68

1.1

1.0

—

Other diseases of pleura

4.10

15.41

1.2

1.1

—

Other diseases of blood and blood-forming organs, wide

6.42

15.35

1.1

1.0

—

Presence of other functional implants

3.82

14.84

1.1

1.0

—

All influenza

31.70

14.78

1.0

—

Acute bronchitis

4.57

14.45

1.3

1.1

—

Liquid cancers, helper endpoint

4.80

14.31

1.1

—

Diseases of the respiratory system

16.91

14.27

1.0

—

Chronic kidney disease

4.83

14.07

1.1

—

COPD, hospital admission 2, with asthma infections

4.63

14.06

1.2

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

4.62

13.68

1.2

1.0

—

Viral infections characterized by skin and mucous membrane lesions

4.45

13.25

1.0

1.1

—

Implicit viral Sepsis

5.72

13.17

1.1

—

Malaise and fatigue

4.42

13.03

1.1

—

Other acute lower respiratory infections

3.79

12.96

1.3

1.1

—

Dyspnoea

141

3.04

12.83

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

4.55

12.78

1.1

1.0

—

Agranulocytosis

17.34

12.49

1.1

1.0

—

Heart failure,strict

3.81

12.49

1.1

—

Drug-induced neutropenia

24.41

12.45

1.1

1.0

—

Other respiratory disorders and diseases

5.34

12.27

1.3

1.0

—

Other diseases of the respiratory system

5.34

12.27

1.3

1.0

—

Pulmonary heart disease

4.52

11.85

1.1

1.0

—

Pulmonary embolism

4.52

11.85

1.1

1.0

—

COPD

3.70

11.69

1.2

1.0

—

Other and unspecified anaemias

3.69

11.54

1.0

1.1

—

Other anaemias

3.68

11.49

1.0

1.1

—

Non-Hodgkin lymphoma, all, including Hilmo

13.61

11.43

1.1

—

Aplastic and other anaemias

100

3.55

11.42

1.0

1.1

—

Hypo-osmolality and hyponatraemia

5.66

11.37

1.1

—

Reimbursement for rheumatic diseases

100

3.59

11.21

1.0

—

Lung diseases due to external agents

8.83

10.74

1.1

1.0

—

Later onset COPD, excluding more controls

15.47

10.72

1.2

1.0

—

Early onset COPD, excluding more controls

21.44

10.66

1.3

1.0

—

4.00

10.51

1.2

1.0

—

Certain infectious and parasitic diseases

3.36

10.27

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

110

3.16

10.26

1.2

1.0

—

All-cause Heart Failure

3.19

9.98

1.1

—

Abnormalities of breathing

2.96

9.94

1.1

—

Persons with potential health hazards related to communicable diseases

4.96

9.90

1.2

1.0

—

Polyarthropathies

3.13

9.89

1.0

1.2

—

Osteonecrosis

26.12

9.81

1.3

1.0

—

Heart failure, strict

3.09

9.50

1.1

—

Implicit viral Sepsis

7.11

9.47

1.1

1.0

—

Viral Sepsis

7.11

9.47

1.1

1.0

—

Osteopathies and chondropathies

104

3.23

9.42

1.2

1.0

—

Other chronic obstructive pulmonary disease

3.42

9.42

1.2

1.0

—

Heart failure and antihypertensive medication

8.59

9.26

1.0

1.1

—

Heart failure and bmi 25plus

3.74

9.16

1.1

1.0

—

Other arthritis (FG)

4.26

9.10

1.0

1.1

—

Other specified/unspecified arthritis

4.41

9.06

1.0

1.1

—

Lung cancer and mesothelioma

14.29

9.00

1.1

1.0

—

General symptoms and signs

2.81

8.85

1.0

1.1

—

Invasive ventilation

14.06

8.68

1.0

—

Chronic lower respiratory diseases

131

2.48

8.60

1.1

—

Suppurative and necrotic conditions of lower respiratory tract

16.34

8.55

1.2

1.0

—

Non-ischemic cardiomyopathy

4.43

8.53

1.0

1.1

—

Valvular heart disease excluding rheumatic fever

3.75

8.49

1.1

—

Non-rheumatic valve diseases

3.74

8.48

1.1

—

Persons encountering health services in other circumstances

3.58

8.46

1.2

1.0

—

DVT of lower extremities and pulmonary embolism

3.22

8.25

1.1

—

COPD, early/later onset

3.04

8.16

1.3

1.0

—

Contact with and exposure to communicable diseases

6.53

7.83

1.2

1.0

—

Any death

106

2.77

7.81

1.1

—

Bronchitis

143

2.42

7.81

1.2

1.1

—

Non-invasive ventilation

11.37

7.78

1.1

1.0

—

COPD related to multimorbidity

3.11

7.75

1.3

1.0

—

COPD, hospital admissions

2.97

7.62

1.2

1.1

—

Spondylosis

102

2.88

7.60

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

139

2.64

7.55

1.1

—

Non-allergic asthma (mode)

18.17

7.55

1.2

1.0

—

Non-follicular lymphoma

8.85

7.53

1.1

1.0

—

Acute tubulo-interstitial nephritis

100

2.93

7.53

1.2

1.1

—

Venous thromboembolism

119

2.84

7.52

1.1

—

Autoimmune diseases related-to ILD

128

2.67

7.47

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3.34

7.36

1.0

1.1

—

118

2.41

7.31

1.1

—

Rheumatoid arthritis, including avohilmo

3.38

7.23

1.0

1.1

—

Abnormal findings on diagnostic imaging of lung

111

2.85

7.14

1.2

1.1

—

Caries of dentine

4.47

7.10

1.3

1.1

—

Thrombocytopenia, unspecified

12.04

7.07

1.0

—

Adjustment and management of implanted device

5.60

7.04

1.2

1.1

—

Basal cell carcinoma, including avohilmo

3.32

6.87

1.0

1.1

—

Enlarged lymph nodes

9.30

6.77

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

5.87

6.59

1.0

—

Disorders of calcium metabolism

12.27

6.58

1.1

1.0

—

ILD medications: azathioprine

10.01

6.52

1.1

1.0

—

Other medical care

2.93

6.51

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

129

2.37

6.51

1.1

—

L04AA Selective immunosuppressants

5.30

6.44

1.1

1.0

—

Disorders of other endocrine glands

3.19

6.34

1.0

1.1

—

Pneumonia due to Haemophilus influenzae

+∞

6.29

1.0

0.0

—

Pneumonitis due to solids and liquids

9.26

6.28

1.0

—

Azathioprine

9.24

6.28

1.1

1.0

—

Hypercalcemia

18.09

6.26

1.1

1.0

—

Persons encountering health services for specific procedures and health care

135

2.27

6.26

1.1

—

Biological medication for rheuma

7.66

6.11

1.0

—

Haemorrhage from respiratory passages

3.24

6.11

1.1

1.0

—

Exposure to unspecified factor

160

2.20

5.93

1.1

—

Purpura and other haemorrhagic conditions

7.24

5.91

1.0

—

Basal cell carcinoma

3.15

5.90

1.0

1.1

—

Exclusions for E4_PCOS_BROAD

6.37

5.84

1.1

1.0

—

Disorders of mineral metabolism

8.02

5.83

1.1

1.0

—

Tumor necrosis factor alpha inhibitors

8.01

5.83

1.0

—

Malignant neoplasm, wide definition for exclusion

2.49

5.82

1.1

—

Other viral diseases

3.75

5.73

1.4

1.0

—

Certain disorders involving the immune mechanism

5.56

5.67

1.4

1.0

—

Other viral diseases

5.15

5.67

1.4

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3.06

5.65

1.0

1.1

—

Malignant neoplasm

2.47

5.62

1.1

—

Osteoporosis

3.58

5.60

1.2

1.0

—

Autoimmune diseases excluding thyroid diseases

121

2.21

5.58

1.1

—

Other necrotizing vasculopathies (FG)

12.90

5.58

1.0

—

Sleep apnoea

138

2.21

5.57

1.1

—

Glomerular diseases

5.37

5.52

1.1

1.0

—

Dental caries

3.63

5.44

1.3

1.0

—

Pyothorax

16.07

5.41

1.3

1.0

—

Other heart diseases, wide

2.40

5.35

1.1

—

L04AD Calcineurin inhibitors

7.87

5.34

1.2

1.0

—

Any gastric operation

3.14

5.30

1.0

—

GASTRO-related operations

3.14

5.30

1.0

—

Streptococcal septicaemia

11.27

5.29

1.1

1.0

—

Pacemaker

2.97

5.18

1.2

1.0

—

Seronegative rheumatoid arthritis

7.35

5.13

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

119

2.16

5.13

1.1

—

Spondylopathies

112

2.24

5.10

1.1

—

Cutaneous abscess, furuncle and carbuncle

3.75

5.08

1.1

1.0

—

Transplanted organ and tissue status

8.35

5.05

1.2

1.0

—

Obesity related asthma

3.08

5.05

1.2

1.0

—

Use of hypnotics and sedatives

138

2.08

5.03

1.1

—

Care involving dialysis

10.02

5.02

1.1

1.0

—

Asthma (diagnoses ohter than nonallergic)

162

2.15

5.00

1.2

1.1

—

Malignant neoplasm of bronchus and lung, including Hilmo

3.81

4.93

1.1

—

Sulfasalazine

4.33

4.92

1.0

1.1

—

Early onset COPD

3.66

4.92

1.3

1.0

—

Low back pain

121

2.26

4.91

1.2

1.1

—

Idiopathic pulmonary fibrosis

7.71

4.84

1.1

1.0

—

Enterocolitis due to Clostridium difficile

7.71

4.84

1.1

1.0

—

Rheumatoid arthritis

3.04

4.84

1.0

1.1

—

Other necrotizing vasculopathies

9.02

4.78

1.0

—

Autoimmune diseases

121

2.06

4.68

1.0

1.1

—

Malignant neoplasm of skin

2.72

4.67

1.0

1.1

—

Other (seronegative) rheumatoid arthritis, wide

4.67

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

110

2.29

4.61

1.2

1.1

—

Dialysis, with operation codes

6.12

4.60

1.1

1.0

—

ILD-related respiratory insufficiency

14.07

4.58

1.1

1.0

—

Herpesviral [herpes simplex] infections

8.19

4.56

1.0

—

Viral infections characterized by skin and mucous membrane lesions

163

2.10

4.53

1.1

—

Atrial fibrillation and flutter with reimbursement

4.95

4.52

1.1

—

Abnormal spermatozoa

4.83

4.49

1.0

—

COPD, hospital admissions 1, only main diagnosis

2.70

4.49

1.2

1.1

—

Non-selective monoamine reuptake inhibitors

2.77

4.43

1.3

1.0

—

Systemic connective tissue disorders

2.82

4.37

1.0

1.1

—

Infections, IBD-co-morbidities

7.15

4.35

1.1

1.0

—

Asthma/COPD (KELA code 203)

131

2.09

4.32

1.2

1.1

—

Nephropathy related operations

5.51

4.28

1.1

1.0

—

Pyogenic arthritis

11.69

4.27

1.1

1.0

—

Ischaemic heart disease, wide definition

106

2.16

4.23

1.2

1.1

—

Calcific aortic valvular stenosis, operated

2.77

4.22

1.1

—

Calcific aortic valvular stenosis

2.77

4.22

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.77

4.22

1.1

—

Operations 2 for CAVS

2.77

4.22

1.1

—

Other heart diseases

3.27

4.22

1.2

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

2.77

4.22

1.1

—

Syncope and collapse

2.81

4.21

1.0

1.1

—

Other/unspecified dorsalgia

2.76

4.20

1.2

1.0

—

Glomerulonephritis

6.93

4.16

1.1

1.0

—

Secondary uncertain malignant neoplasm

6.93

4.16

1.1

—

Methotrexate

6.93

4.16

1.0

1.1

—

Hernia of abdominal wall, postoperative

5.89

4.12

1.1

1.0

—

COPD-related respiratory insufficiency

4.62

4.05

1.2

1.0

—

Adalimumab

10.01

4.01

1.0

—

Ischemic heart diseases

105

2.12

4.00

1.1

—

Erysipelas

2.32

3.98

1.0

—

Emphysema

6.44

3.98

1.3

1.0

—

Anaemias

7.35

3.94

1.1

1.0

—

Oedema, not elsewhere classified

3.29

3.94

1.2

1.1

—

Lower back pain or/and sciatica

161

1.91

3.94

1.1

—

Atrial fibrillation and flutter

4.13

3.92

1.1

1.0

—

Any event in cancer register

105

2.08

3.81

1.1

—

FESS (DNB20)

6.01

3.81

1.0

—

Explicit bacterial Sepsis

6.01

3.81

1.1

1.0

—

Heart failure and coronary heart disease

2.46

3.80

1.1

—

Other and unspecified drugs and medicaments

8.76

3.77

1.1

1.0

—

Gout, unspecified

3.19

3.77

1.0

1.1

—

Fungal Sepsis

12.04

3.76

1.0

—

Dorsalgia

121

1.95

3.75

1.1

—

Oxycodone

2.53

3.72

1.2

1.1

—

Cardiodefibrillation

2.44

3.68

1.2

1.0

—

Other or unspecified ileus, impaction or obstruction

3.83

3.68

1.3

1.1

—

Later onset COPD

2.61

3.66

1.2

1.0

—

Unspecified acute lower respiratory infection

5.63

3.65

1.6

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

3.64

3.65

1.1

—

Sleep apnoea, including avohilmo

139

1.92

3.64

1.1

—

3.14

3.63

1.0

—

Tramadol

100

2.09

3.61

1.1

—

Bacterial intestinal infections, IBD co-morbidities

4.00

3.59

1.1

1.0

—

Personality disorders

4.00

3.59

1.4

1.0

—

Injury of muscle and tendon at lower leg level

4.77

3.55

1.0

—

Cardiomyopathy

4.77

3.55

1.1

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3.16

3.53

1.1

—

Non-small cell lung cancer, including Hilmo

4.32

3.53

1.2

1.1

—

Solid cancers, helper endpoint

2.12

3.51

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.16

3.50

1.1

1.0

—

Kidney transplant status

10.02

3.50

1.2

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

10.01

3.49

1.2

1.0

—

Emotionally unstable personality disorder

10.01

3.49

1.3

1.0

—

Fracture of foot, except ankle

3.61

3.49

1.2

1.0

—

Acute sinusitis

2.43

3.45

1.1

—

Chronic sinusitis

2.47

3.44

1.1

1.0

—

Hypokalaemia

4.55

3.42

1.3

1.0

—

Other bacterial intestinal infections

3.75

3.38

1.1

1.0

—

Personality disorders, excluding more controls

3.75

3.38

1.4

1.0

—

Ethmoidectomy

5.01

3.36

1.0

—

Implicit fungal Sepsis

7.01

3.36

1.1

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

7.01

3.36

1.6

1.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

7.01

3.36

1.1

1.0

—

Aortic aneurysm

2.83

3.33

1.4

1.0

—

Myocardial infarction

2.25

3.31

1.2

1.1

—

Gout, FINNGEN

2.53

3.27

1.0

1.1

—

Extracorporeal dialysis

8.59

3.26

1.0

—

Persons encountering health services for specific procedures, not carried out

8.58

3.26

1.2

1.0

—

Brachial plexus disorders

8.58

3.26

1.0

—

Parasetamol

2.24

3.25

1.0

1.1

—

Hyperkalaemia

6.38

3.18

1.0

—

Gout

2.52

3.16

1.0

1.2

—

Malignant neoplasm of bronchus and lung

3.56

3.13

1.2

1.1

—

AV-block

4.18

3.13

1.2

1.0

—

Opioids

103

1.92

3.13

1.0

1.1

—

Certain infectious and parasitic diseases

2.28

3.10

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

2.10

3.10

1.2

1.1

—

Other viral diseases, not elsewhere classified

4.49

3.10

1.6

1.0

—

Used for control exclusion in common control thyroid runs

115

1.85

3.08

1.0

1.1

—

Pleural effusion

3.67

3.08

1.1

1.0

—

Other and unspecified psoriasis

7.51

3.05

1.0

—

Cardiomyopathy, other and unspecified

7.51

3.05

1.2

1.0

—

Coronary atherosclerosis

2.08

3.03

1.3

1.1

—

Mycoses

2.89

3.02

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

5.84

3.02

1.0

—

Cardiac arrhythmias

2.54

3.01

1.1

—

Seropositive rheumatoid arthritis, strict definition

4.29

2.99

1.0

—

Poisoning by medicine

4.29

2.99

1.1

1.0

—

Poisoning by drugs, medicaments and biological substances

4.29

2.99

1.1

1.0

—

Chronic apical periodontitis

145

1.77

2.98

1.1

—

Allergic urticaria

10.01

2.98

1.0

—

Abnormal results of function studies

10.01

2.98

1.0

—

Erysipelas

2.27

2.98

1.0

—

Hypothyroidism and >3 levothyroxin purchases

5.65

2.97

1.0

—

Hypothyroidism, levothyroxine purchases

5.65

2.97

1.0

—

Hypothyroidism (congenital or acquired)

5.65

2.97

1.0

—

Codeine

103

1.90

2.94

1.1

—

Allergic asthma (mode)

9.79

2.94

1.2

1.0

—

Iron deficiency anaemia

2.23

2.92

1.1

—

Other pleural conditions

4.71

2.91

1.0

—

Glomerular disorders in diseases classified elsewhere

4.71

2.91

1.1

1.0

—

Other cataract

2.27

2.90

1.1

—

Asthma, including avohilmo

157

1.72

2.89

1.1

—

Malignant neoplasm of breast, HER2-negative

2.86

2.89

1.2

1.0

—

Malignant neoplasm of breast

2.85

2.87

1.2

1.0

—

Other viral diseases, not elsewhere classified

3.68

2.86

1.5

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

141

1.92

2.81

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.00

2.80

0.0

1.1

—

Gout, idiopatic and unspecified

2.54

2.78

1.0

1.1

—

Pain, not elsewhere classified

3.57

2.78

1.2

1.1

—

Gout, strict definition

3.08

2.76

1.0

—

Schizoaffective disorder

8.34

2.75

1.0

—

Other specified and unspecified personality disorders

8.34

2.75

1.2

1.0

—

Percutaneous Coronary Intervention

103

1.90

2.73

1.1

—

Mucosal proctocolitis

5.00

2.72

1.4

1.0

—

Coronary revascularization (ANGIO or CABG)

103

1.90

2.72

1.1

—

Other fall from one level to another

3.24

2.72

1.0

—

Malignant neoplasm of breast, HER-positive

3.12

2.71

1.3

1.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

2.75

2.70

1.2

1.0

—

Malignant neoplasm of breast, including Hilmo

2.75

2.70

1.2

1.0

—

Other complications of surgical and medical care, not elsewhere classified

6.01

2.70

1.2

1.0

—

Suicide or other Intentional self-harm

3.45

2.68

1.2

1.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

3.09

2.68

1.3

1.0

—

Injuries to the thorax

105

2.09

2.67

1.0

1.1

—

Substance use, excluding alcohol

3.75

2.67

1.6

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

1.84

2.66

1.0

1.1

—

Examination and observation for other reasons

110

0.32

2.64

1.0

1.1

—

Finngen Rheumatological endpoints

113

1.81

2.62

1.0

1.1

—

Seropositive rheumatoid arthritis

2.78

2.62

1.0

1.1

—

Paralytic ileus and intestinal obstruction

2.46

2.61

1.3

1.1

—

Persons encountering health services in other circumstances, wide

148

1.67

2.60

1.1

—

Fracture at wrist and hand level

2.54

2.60

1.1

1.0

—

Zoster [herpes zoster]

3.34

2.60

1.1

1.0

—

Type 2 diabetes, wide definition

124

1.81

2.59

1.2

1.1

—

Emergency coronary revascularization (for ACS)

122

1.79

2.58

1.1

—

Volume depletion

4.00

2.56

1.4

1.0

—

Vocal cord dysfunction

7.48

2.56

1.0

—

L01XE Protein kinase inhibitors

7.16

2.55

1.0

—

Lichen simplex chronicus and prurigo

7.15

2.55

1.0

—

Nail disorders

7.15

2.55

1.0

—

Reactive arthropathies

7.15

2.55

1.0

—

Other bacterial intestinal infections

2.73

2.54

1.1

1.0

—

Other CVD

2.73

2.54

1.3

1.0

—

Other CVD (FINNGEN)

5.82

2.53

1.7

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

107

1.95

2.51

1.0

1.1

—

Metabolic disorders

133

1.74

2.50

1.1

—

Hydronephrosis

4.38

2.47

1.0

—

In situ neoplasms

2.20

2.46

1.0

1.1

—

Fracture of rib(s), sternum and thoracic spine

2.38

2.45

1.1

1.0

—

Missing teeth due to accident, extraction or parodontitis

142

1.86

2.45

1.1

—

Intestinal infectious diseases

169

1.71

2.43

1.1

—

Pregnancy hypertension

0.00

2.43

0.0

1.1

—

Disorders of adult personality and behaviour

3.13

2.43

1.2

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3.13

2.43

1.2

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

111

0.38

2.42

1.0

1.1

—

Other and unspecified iron deficiency

2.29

2.40

1.2

1.0

—

Duodenal ulcer

3.34

2.39

1.0

—

Thoracic aortic aneurysm

3.34

2.39

1.1

1.0

—

Osteoporosis with pathological fracture (FG)

6.26

2.37

1.2

1.3

—

Scoliosis

6.26

2.37

1.2

1.1

—

Peritonsillar abscess

3.64

2.36

1.0

—

Acute pancreatitis (for exclusion)

3.03

2.35

1.1

1.0

—

Nausea and vomiting

2.50

2.34

1.1

1.0

—

Deep bite

6.27

2.32

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

161

1.75

2.32

1.1

—

Other disorders of bladder

3.22

2.30

1.3

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

135

1.70

2.29

1.1

—

Conduction disorders

2.63

2.29

1.2

1.0

—

Intracranial trauma

2.01

2.28

1.1

—

Acute appendicitis, with complications

2.94

2.27

1.2

1.0

—

4.62

2.27

1.2

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.69

2.27

1.4

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.55

2.26

1.0

—

Fracture of lumbar spine and pelvis

2.55

2.26

1.3

1.0

—

Myocardial infarction, unclassifiable

2.47

2.25

1.1

—

Intestinal stricture

2.27

2.24

1.3

1.0

—

Viral warts

5.56

2.21

1.0

—

Disorders of refraction and accommodation

2.85

2.19

1.0

—

Diabetes, varying definitions

138

1.66

2.17

1.1

—

Diseases of the skin and subcutaneous tissue

117

1.67

2.16

1.0

1.1

—

Major coronary heart disease event

115

1.73

2.16

1.1

—

Gastroduodenal ulcer

2.23

2.15

1.1

—

Hypothyroidism, drug reimbursement

5.88

2.15

1.0

—

Other/unspecified rheumatoid arthritis

3.69

2.15

1.0

1.1

—

Somatoform disorder

3.69

2.15

1.1

1.0

—

Other retinal disorders

122

1.79

2.14

1.0

1.1

—

Non-small cell lung cancer

4.26

2.13

1.2

1.1

—

Gonarthrosis [arthrosis of knee](FG)

1.78

2.13

1.0

1.1

—

Bleeding

143

1.69

2.12

1.1

—

Hypertensive heart and/or renal disease

2.43

2.10

1.1

1.0

—

Sequelae of external causes of morbidity and mortality

2.45

2.10

1.3

1.1

—

Other/unspecified seropositive rheumatoid arthritis

2.45

2.10

1.0

—

L02BG Aromatase inhibitors

2.45

2.09

1.3

1.0

—

Pneumothorax

5.01

2.07

1.0

—

Myopia

5.00

2.07

1.0

—

Herpesviral [herpes simplex] infections

2.70

2.06

1.0

—

Concussion

2.01

2.06

1.1

—

Schizophrenia or delusion, excluding more controls

2.43

2.05

1.3

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.69

2.05

1.2

1.0

—

Sarcoidosis

3.50

2.05

1.1

1.0

—

Valvular operations

3.50

2.05

1.0

—

Diabetes mellitus

140

1.63

2.05

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.32

2.04

1.1

1.0

—

Problems related to lifestyle

4.00

2.04

1.2

1.0

—

Rheumatism, unspecified

4.00

2.04

1.2

1.1

—

Acute upper respiratory infections

153

1.61

2.04

1.1

—

Coxarthrosis [arthrosis of hip](FG)

1.86

2.03

1.2

1.1

—

Seropositive rheumatoid arthritis, wide

2.40

2.02

1.0

1.1

—

Gonarthrosis

1.81

2.02

1.0

1.1

—

Psoriasis

2.40

2.02

1.0

1.1

—

Schizophrenia or delusion

2.40

2.02

1.3

1.0

—

Constipation

152

1.64

2.01

1.2

1.1

—

Delirium, not induced by alcohol and other psychoactive substances

3.07

2.00

1.1

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.05

2.00

1.2

1.0

—

Sleep disorders (combined)

138

1.60

2.00

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

124

1.63

2.00

1.1

—

Acute suppurative otitis media

3.44

2.00

1.0

1.1

—

Sequelae with surgical and medical care as external cause

2.63

2.00

1.4

1.0

—

Acute pancreatitis

2.63

2.00

1.1

1.0

—

Traumatic subdural haemorrhage

3.07

2.00

1.0

1.1

—

Codeine or tramadol medication

149

1.58

1.98

1.1

—

Presbycusis

2.79

1.97

1.1

—

Type 2 diabetes

137

1.62

1.97

1.1

—

Sensorineural hearing loss

129

1.68

1.97

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

156

1.60

1.96

1.1

—

Bipolar affective disorders

3.33

1.96

1.1

1.0

—

Nonorganic sleeping disorders, excluding more controls

3.33

1.96

1.7

1.0

—

Headache

1.97

1.95

1.1

—

Schizophrenia, schizotypal and delusional disorders

2.35

1.94

1.3

1.0

—

Bronchiectasis

4.55

1.94

1.0

—

Faecal incontinence

4.55

1.94

1.0

—

Hypotension

2.57

1.93

1.4

1.0

—

Nerve, nerve root and plexus disorders

164

1.57

1.93

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

3.75

1.93

1.2

1.1

—

Candidiasis

3.75

1.93

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.00

1.89

1.1

1.0

—

Nutritional anaemias

109

1.86

1.89

1.1

—

Acute appendicitis

147

1.72

1.89

1.2

1.1

—

Presence of other devices

0.00

1.88

0.0

1.1

—

5-aminosalicylic acid

3.18

1.88

1.4

1.0

—

Fall on same level

151

1.55

1.87

1.1

—

Diseases of arteries, arterioles and capillaries

132

1.68

1.87

1.2

1.0

—

Hypertensive Heart Disease

2.46

1.86

1.1

1.0

—

Other diseases of liver

2.86

1.86

1.0

—

Superficial injury of hip and thigh

2.86

1.86

1.0

—

Convulsions, not elsewhere classified

3.14

1.85

1.1

—

Seborrhoeic dermatitis

3.53

1.83

1.0

—

Unspecified kidney failure

3.53

1.83

1.0

—

Suggestive for eosinophilic asthma

4.17

1.82

1.0

—

Complications of surgical and medical care, not elsewhere classified

171

1.56

1.82

1.2

1.1

—

Other disorders of veins

2.01

1.82

1.1

1.0

—

Appendectomy

124

1.77

1.80

1.3

1.0

—

Inflammatory bowel disease

2.27

1.80

1.2

1.0

—

Mental and behavioural disorders due to psychoactive substance use

134

1.73

1.80

1.2

1.1

—

Other (not insulin) diabetes medications

143

1.58

1.80

1.1

—

Papulosquamous disorders

2.00

1.79

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.76

1.79

1.1

1.0

—

Persistent mood disorders

2.76

1.79

1.5

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

122

1.66

1.78

1.1

—

Hypothyroidism, strict autoimmune

104

1.71

1.76

1.1

—

Conductive and sensorineural hearing loss

133

1.62

1.75

1.1

—

Amiodarone users

3.34

1.74

1.2

1.0

—

Other bursopathies

3.34

1.74

1.2

1.0

—

Ulcerative colitis, NAS

3.34

1.74

1.5

1.0

—

Other diseases of oesophagus

3.34

1.74

1.0

—

Other and unspecified nonorganic psychotic disorders

3.33

1.74

1.5

1.1

—

Angina pectoris

1.81

1.74

1.0

1.1

—

2.04

1.73

1.0

1.1

—

Pain in limb

127

1.63

1.73

1.1

—

Specific personality disorders

2.92

1.72

1.3

1.0

—

Other disorders of ear

145

1.58

1.72

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

135

1.60

1.71

1.1

—

Other infectious diseases

3.85

1.71

1.2

1.0

—

Pruritus

3.85

1.71

1.2

1.0

—

Other and unspecified tonsillitis

2.69

1.70

1.1

1.0

—

Other hearing loss

2.12

1.68

1.2

1.1

—

Neoplasms

1.79

1.68

1.0

1.1

—

Spinal stenosis

100

1.75

1.67

1.0

1.1

—

Monoamine oxidase A inhibitors

3.16

1.66

1.3

1.0

—

Benzodiazepine use

171

1.53

1.65

1.2

1.1

—

Open wound of lower leg

2.80

1.65

1.0

—

Coxarthrosis

1.77

1.63

1.2

1.1

—

Appendicitis, broad definition

156

1.62

1.2

1.1

—

Insulin medication

119

1.70

1.61

1.0

1.1

—

Carcinoma in situ of skin of other and unspecified parts of face

3.58

1.61

1.0

—

Paroxysmal tachycardia

3.14

1.61

1.2

1.0

—

Other systemic involvement of connective tissue (FG)

2.35

1.59

1.0

1.1

—

Kela-code for severe mental illness

2.06

1.59

1.4

1.1

—

Urticaria and erythema

2.06

1.59

1.2

1.0

—

Substance abuse, excluding more controls

115

1.71

1.58

1.2

1.0

—

D07AA Corticosteroids, weak (group I)

3.00

1.57

1.2

1.0

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2.99

1.57

1.0

1.1

—

Depression medications

3.35

1.57

1.0

—

Diseases of appendix

157

1.61

1.57

1.2

1.1

—

Disorders of the thyroid gland

148

1.54

1.56

1.1

—

133

1.66

1.56

1.2

1.1

—

Hypothyroidism, other/unspecified

134

1.57

1.55

1.1

—

Diabetes medication

144

1.52

1.55

1.1

—

Noninfective enteritis and colitis

1.85

1.55

1.2

1.1

—

Episodal and paroxysmal disorders

127

1.52

1.54

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

152

1.51

1.54

1.1

—

Effects of foreign body entering through natural orifice

0.00

1.52

0.0

1.0

—

Fall on and from ladder

3.34

1.52

1.0

—

Normotensive glaucoma

3.34

1.52

1.0

1.1

—

Cardiomyopathies, Primary/intrinsic

3.34

1.52

1.2

1.0

—

Crohn disease

3.34

1.52

1.0

—

Atrophic disorders of skin

3.34

1.52

1.0

1.1

—

Budesonide

3.33

1.52

1.0

—

Nonorganic sleeping disorders

2.59

1.51

1.7

1.0

—

Diseases of oesophagus, stomach and duodenum

156

1.49

1.51

1.2

1.1

—

Other disorders of kidney and ureter

2.86

1.50

1.0

—

Injuries to the knee and lower leg

163

1.46

1.49

1.1

—

Insulin, fast-acting

2.00

1.48

1.1

1.0

—

Ulcerative colitis

2.43

1.47

1.3

1.0

—

Other soft tissue disorders, not elsewhere classified

130

1.53

1.47

1.1

—

Medicines for HER+ breast cancer

2.07

1.47

1.3

1.1

—

Type 2 diabetes, definitions combined

135

1.52

1.47

1.1

—

Candidiasis

2.22

1.46

1.1

1.0

—

Myocardial infarction, with ST-elevation

2.37

1.45

1.3

1.0

—

Voice disturbances

2.12

1.44

1.0

—

Cardiomyopathy (excluding other)

3.13

1.44

1.2

1.0

—

Endometriosis ASRM stages 1,2

3.13

1.44

1.2

1.0

—

Malignant neoplasm of rectum, including Hilmo

3.13

1.44

1.0

1.1

—

Thiazolidinediones

2.73

1.43

1.2

1.0

—

Benign neoplasm of other and unspecified endocrine glands

2.73

1.43

1.0

—

Complications of medical and surgical care

165

1.56

1.42

1.2

1.1

—

Other disorders of urethra and urinary system

117

1.60

1.42

1.2

1.1

—

Substance abuse

132

1.64

1.41

1.2

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.75

1.39

1.1

—

Congenital malformations of the circulatory system

3.03

1.39

1.0

—

Type 2 diabetes, strict (exclude DM1)

137

1.50

1.39

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

136

1.50

1.38

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.64

1.38

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.96

1.37

1.0

1.1

—

Biguanides

143

1.49

1.37

1.1

—

Mixed conductive and sensorineural hearing loss

2.61

1.36

1.0

—

Other condition

2.94

1.36

1.2

1.0

—

Schizophrenia

2.94

1.36

1.8

1.0

—

Other disorders of penis

2.94

1.36

1.0

1.1

—

Disorders of skin appendages

1.83

1.34

1.0

1.1

—

Pre-eclampsia or poor fetal growth

0.00

1.34

0.0

1.0

—

Other diseases of urinary system

146

1.46

1.34

1.1

—

Anomalies of dental arch relationship, including avohilmo

2.58

1.33

1.0

—

Symptoms and signs involving speech and voice

1.91

1.33

1.0

1.1

—

Any reimbursement code in KELA

2.28

1.32

1.0

1.1

—

Cerebrovascular diseases (FINNGEN)

2.46

1.32

1.0

—

Hypertensive diseases (excluding secondary)

2.05

1.32

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.53

1.31

1.0

—

Suppurative and unspecified otitis media

2.10

1.29

1.0

1.1

—

Mood [affective] disorders

160

1.46

1.29

1.2

1.1

—

Other diseases of the digestive system

1.84

1.29

1.0

1.1

—

Other specific joint derangements/joint disorders

1.60

1.28

1.0

1.1

—

Diseases of the myoneural junction and muscle

2.78

1.28

1.2

1.0

—

Orchitis and epididymitis

2.78

1.28

1.2

1.1

—

Degeneration of macula and posterior pole

102

1.64

1.28

1.0

1.1

—

Other antidepressants

130

1.46

1.27

1.2

1.1

—

Other arthrosis

1.67

1.27

1.1

—

Nonsuppurative otitis media

2.47

1.26

1.0

—

Myocardial infarction, without ST-elevation

1.69

1.25

1.0

1.1

—

Depression

152

1.47

1.25

1.2

1.1

—

Mood disorders

161

1.45

1.25

1.2

1.1

—

Infections of the skin and subcutaneous tissue

129

1.61

1.25

1.1

—

GI-bleeding

1.82

1.25

1.0

1.1

—

Gonarthrosis,primary

148

1.46

1.25

1.1

—

Other mental disorders due to brain damage and dysfunction and to physical disease

2.40

1.24

1.2

1.0

—

Other disorders of the musculoskeletal system and connective tissue

2.40

1.24

1.2

1.0

—

Misadventures to patients during surgical and medical care

2.40

1.24

1.0

—

Covid-19 suspected case

2.40

1.24

1.5

1.0

—

Acute alcohol intoxication, ICD10

2.22

1.24

1.5

1.0

—

Superficial injury of lower leg

2.22

1.24

1.1

1.0

—

Endocrine, nutritional and metabolic diseases

1.64

1.23

1.0

1.1

—

Insulin, fast-acting or short human

1.86

1.23

1.1

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

2.00

1.23

1.1

1.0

—

Other systemic involvement of connective tissue

2.04

1.21

1.0

—

Benign neoplasm: Caecum

2.63

1.21

1.0

—

Dermatophytosis

2.63

1.21

1.0

—

Noninfectious colitis NAS

2.63

1.21

1.2

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

2.16

1.21

1.0

—

Mouth breathing

1.79

1.20

1.1

—

Myocardial infarction, strict

1.69

1.20

1.2

1.1

—

Medical observation and evaluation for suspected diseases and conditions

111

0.55

1.20

1.0

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

132

1.59

1.19

1.0

1.1

—

Alcohol use disorder, Swedish definition

128

1.58

1.19

1.2

1.1

—

Other arrhythmias

1.68

1.19

1.1

—

Pain in throat and chest

1.55

1.17

1.0

1.1

—

Umbilical hernia

1.88

1.17

1.1

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.93

1.16

1.2

1.1

—

Deforming dorsopathies

2.00

1.16

1.1

—

Injuries to the hip and thigh

1.65

1.15

1.1

—

Other noninfective gastroenteritis and colitis

2.05

1.15

1.1

—

Dermatitis

141

1.55

1.15

1.1

—

Unspecified mental disorder

1.81

1.14

1.4

1.1

—

Hyperlipidaemia, other/unspecified

1.67

1.14

1.0

1.1

—

Psoriasis vulgaris

2.33

1.12

1.0

—

Viral warts

2.33

1.12

1.1

1.0

—

Dysphagia

1.90

1.12

1.4

1.1

—

Acute alcohol intoxication

1.96

1.11

1.4

1.0

—

Type of accident

1.96

1.11

1.2

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

145

1.51

1.11

1.0

1.1

—

Diseases of the ear and mastoid process

140

1.40

1.11

1.0

1.1

—

Mental and behavioural disorders due to alcohol

122

1.58

1.10

1.2

1.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1.98

1.10

1.0

—

Pleural plaque with presence of asbestos

2.38

1.09

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

2.38

1.09

1.6

1.0

—

Special screening examination for other diseases and disorders

2.38

1.09

1.0

1.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.22

1.09

1.0

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

0.48

1.08

1.0

1.1

—

Disease of hard tissues of teeth, NOS

1.61

1.08

1.0

1.1

—

IBD patients in KELA-register

2.19

1.08

1.4

1.0

—

Inflammatory bowel disease, strict (require KELA)

2.19

1.08

1.4

1.0

—

Intracranial injury

129

1.54

1.06

1.1

—

Cough

1.76

1.05

1.2

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

2.12

1.05

1.1

1.0

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

2.34

1.04

1.0

—

Intestinal infectious diseases

167

1.37

1.04

1.1

—

Vascular dementia

2.30

1.04

1.6

1.0

—

Dilated cardiomyopathy

2.27

1.03

1.2

1.0

—

Other inflammation of eyelid

2.27

1.03

1.0

—

Atopic dermatitis

0.47

1.02

1.0

1.1

—

Open wound of head

133

1.52

1.02

1.0

1.1

—

Gastro-oesophageal reflux disease

140

1.48

1.01

1.1

—

Disorders of choroid and retina

150

1.42

1.01

1.0

1.1

—

Antenatal screening

0.00

1.00

0.0

1.1

—

Urticaria

1.88

1.00

1.1

1.0

—

Enthesopathies of lower limb, excluding foot

2.00

1.00

1.1

—

Open wound of wrist and hand

1.65

0.99

1.1

—

Disorders of parathyroid gland

1.98

0.98

1.0

1.1

—

severe traumatic brain injury, does not include concussion

1.84

0.98

1.0

1.1

—

Pre-eclampsia or eclampsia

0.00

0.97

0.0

1.0

—

Acute appendicitis, no complications

107

1.58

0.97

1.2

1.1

—

Rotator cuff syndrome

111

1.49

0.97

1.0

1.1

—

Otitis externa

1.95

0.97

1.0

—

Other enthesopathies

1.85

0.96

1.2

1.0

—

Gestational [pregnancy-induced] hypertension

0.00

0.96

0.0

1.0

—

Mood disorders, excluding more controls

137

1.39

0.95

1.1

—

Neurological diseases, wide definition

2.32

0.95

1.0

—

Hypertensive diseases

1.49

0.95

1.0

1.1

—

Hypertension

1.49

0.95

1.0

1.1

—

Hard cardiovascular diseases

112

1.44

0.94

1.0

1.1

—

Unspecified haematuria

1.55

0.94

1.1

—

Adenomyosis (Endometriosis of uterus)

2.22

0.93

1.2

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2.22

0.93

1.0

—

Other diseases of intestines

146

1.36

0.91

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

109

1.55

0.91

1.2

1.0

—

Adhesive capsulitis of shoulder

2.14

0.91

1.0

—

Injuries to the head

169

1.35

0.91

1.1

—

Carpal tunnel syndrome

118

1.49

0.90

1.2

1.1

—

Diseases of external ear

1.75

0.90

1.1

1.0

—

Necrosis of pulp, including avohilmo

118

1.52

0.89

1.1

—

Nasal polyp

2.07

0.89

1.0

—

Selective serotonin reuptake inhibitors

130

1.37

0.89

1.2

1.1

—

Dementia in Alzheimer disease

1.88

0.87

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

166

1.35

0.87

1.1

—

Leisure time condition

2.00

0.87

1.2

1.0

—

Viral and other specified intestinal infections

2.00

0.86

1.2

1.0

—

Complications of labour and delivery

0.51

0.86

1.0

1.1

—

Recurrent or chronic depression

1.66

0.86

1.2

1.0

—

Malignant neoplasm of digestive organs

1.69

0.86

1.2

1.1

—

Coronary artery bypass grafting

1.74

0.86

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

110

1.51

0.85

1.1

—

Care involving use of rehabilitation procedures

125

1.47

0.85

1.2

1.1

—

Persons encountering health services in circumstances related to reproduction

0.53

0.85

1.2

1.1

—

Redundant prepuce, phimosis and paraphimosis

1.80

0.85

1.0

1.1

—

Spondylolisthesis/Spondylolysis

1.94

0.84

1.2

1.1

—

Pedal cyclist injured in transport accident

1.94

0.84

1.2

1.0

—

Erosion of teeth , including avohilmo

1.94

0.84

1.2

1.0

—

Atopic dermatitis, strict definition with reimbursement

1.93

0.84

1.2

1.0

—

Periodontitis

164

1.35

0.84

1.0

1.1

—

Varicose veins

109

1.45

0.83

1.0

1.1

—

Actinic keratosis

1.56

0.83

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

147

1.33

0.82

1.1

—

Genitourinary diseases

1.53

0.82

1.0

1.1

—

Lumbar disc prolapse

111

1.45

0.82

1.1

—

Diseases of middle ear and mastoid

1.54

0.82

1.0

1.1

—

Organic, including symptomatic, mental disorders

1.47

0.82

1.2

1.0

—

Shoulder lesions

118

1.39

0.81

1.0

1.1

—

Complications of procedures, not elsewhere classified

163

1.37

0.80

1.1

—

Coxarthrosis, primary, with hip surgery

114

1.48

0.79

1.2

1.1

—

Hernia of abdominal wall

114

1.49

0.79

1.1

—

Other hammer toe(s) (acquired)

0.00

0.79

0.0

1.1

—

Use of pramipexole

1.67

0.78

1.1

—

Hypertension, essential

1.43

0.77

1.0

1.1

—

Diseases of the digestive system

114

1.48

0.77

1.0

1.1

—

Foreign body on external eye

0.00

0.77

0.0

1.0

—

L02BB Anti-androgens

0.00

0.76

0.0

1.0

—

Colorectal adenocarcinoma

1.76

0.76

1.3

1.1

—

Other external causes of accidental injury

1.39

0.76

1.0

1.1

—

Alzheimer’s disease (Atypical or mixed)

2.16

0.76

1.0

—

Skin changes due to chronic exposure to nonionizing radiation

1.52

0.75

1.0

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

112

1.47

0.75

1.2

1.1

—

Medical abortion

0.52

0.75

1.0

1.1

—

STROKE

1.51

0.75

1.0

1.1

—

Spondyloarthritis

2.08

0.74

1.2

1.0

—

135

1.41

0.73

1.2

1.1

—

Other and unspecified polyneuropathies, also in other diseases

1.84

0.73

1.1

1.0

—

Nontoxic multinodular goitre

1.84

0.73

1.0

—

Benign neoplasm: Skin of eyelid, including canthus

2.00

0.72

1.0

—

Cholecystitis

2.00

0.72

1.0

—

Primary open-angle glaucoma, strict

1.61

0.71

1.1

1.0

—

Pleural plaque

1.92

0.70

1.0

—

Other and unspecified dermatitis

109

1.47

0.70

1.2

1.0

—

Alcohol use disorder, ICD-based

101

1.49

0.70

1.1

—

Disorders of gallbladder, biliary tract and pancreas

160

1.30

0.69

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.41

0.69

1.1

—

Triptan medication for migraine, single purchase ok

1.41

0.69

1.1

—

Dental caries, including avohilmo

1.36

0.67

1.0

1.1

—

Unstable angina pectoris

1.53

0.67

1.1

—

Meniscus derangement

1.43

0.66

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.40

0.66

1.0

1.1

—

Endometriosis of pelvic peritoneum

1.77

0.65

1.2

1.1

—

Pain in joint

1.41

0.65

1.0

1.1

—

Antihypertensive medication - note that there are other indications

1.62

0.65

1.1

—

Statin medication

0.64

0.65

1.0

1.1

—

Insulin, intermediate and long-acting

133

1.39

0.64

1.1

—

Dental operations

1.41

0.64

1.0

1.1

—

Adverse effects, not elsewhere classified

1.72

0.64

1.0

—

Infections with a predominantly sexual mode of transmission

1.72

0.63

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.40

0.63

1.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

1.49

0.63

1.0

1.1

—

Diseases of male genital organs

1.41

0.63

1.1

—

Cholecystectomy

148

1.34

0.63

1.0

1.1

—

Cardiovascular diseases

1.60

0.62

1.0

1.1

—

Deviated nasal septum

1.55

0.61

1.1

—

Other symptoms and signs involving the digestive system and abdomen

1.67

0.61

1.4

1.0

—

Follicular cysts of skin and subcutaneous tissue

1.67

0.61

1.0

—

Hydrocele

1.67

0.61

1.0

1.1

—

Glaucoma

126

1.37

0.61

1.1

—

Premature rupture of membranes

0.00

0.61

0.0

1.1

—

Accidents

1.33

0.61

1.0

1.1

—

Maternal care for other known or suspected fetal problems

0.00

0.60

0.0

1.1

—

Pregnancy with abortive outcome

0.59

0.60

1.0

1.1

—

Dementia

1.43

0.60

1.1

1.0

—

0.00

0.60

0.0

1.0

—

Benign neoplasm: Transverse colon

0.00

0.60

0.0

1.0

—

Primary open-angle glaucoma

1.51

0.60

1.1

—

Hallux valgus (acquired)

1.60

0.60

1.1

—

Fenamates

1.77

0.59

1.2

—

Diseases of liver

1.53

0.59

1.0

1.1

—

Pre-eclampsia

0.00

0.58

0.0

1.0

—

Superficial injury of wrist and hand

0.00

0.58

0.0

1.0

—

Colonic or urogenital fistula

1.51

0.58

1.0

—

Arthrosis

1.34

0.57

1.0

1.1

—

Visual disturbances and blindness

116

0.60

0.57

1.0

1.1

—

1.42

0.57

1.0

1.1

—

Retention of urine

1.46

0.56

1.1

—

Primary gonarthrosis, bilateral

113

1.36

0.56

1.1

—

Abnormal serum enzyme levels

0.56

1.2

1.1

—

Diseases of inner ear

120

1.37

0.55

1.1

—

Injuries to the wrist and hand

171

1.26

0.54

1.0

1.1

—

Abnormalities of heart beat

1.50

0.54

1.0

1.1

—

Caries of dentine, including avohilmo

103

1.29

0.53

1.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.54

0.53

1.0

—

Other and unspecified effects of external causes

1.54

0.53

1.0

—

Gastric ulcer

1.54

0.53

1.2

1.1

—

Chronic periodontitis, including avohilmo

166

1.25

0.53

1.0

1.1

—

Wet age-related macular degeneration

1.53

0.52

1.0

—

Injuries to the elbow and forearm

133

1.32

0.52

1.1

—

Diabetic retinopathy, strict definition

1.51

0.52

1.2

1.1

—

Glucosamine medication

1.37

0.51

1.1

—

Other benign neoplasms of skin

1.45

0.51

1.0

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

165

0.71

0.51

1.1

—

Benign neoplasm: Colon

150

0.70

0.51

1.0

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.60

0.50

1.0

1.1

—

Peripheral arterial reconstruction

1.46

0.50

1.0

—

Diverticular disease of intestine

125

1.28

0.50

1.0

1.1

—

Other headache syndromes

1.49

0.49

1.1

1.0

—

Other dorsopathies, not elsewhere classified

121

1.25

0.49

1.1

—

Coxarthrosis, primary

137

1.30

0.49

1.2

1.1

—

Glaucoma suspect

1.43

0.49

1.0

—

Fissure and fistula of anal and rectal regions

1.56

0.48

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

155

0.73

0.48

1.0

1.1

—

Visual disturbances

109

0.64

0.48

1.0

—

Obesity

123

1.33

0.48

1.2

1.0

—

Other joint disorders

1.28

0.47

1.0

1.1

—

Disorders of lens

101

1.30

0.47

1.0

1.1

—

Hyperplasia of prostate

1.39

0.47

1.0

1.1

—

Zoster [herpes zoster]

109

1.35

0.47

1.1

—

Combinations of oral blood glucose lowering drugs

1.47

0.47

1.0

1.1

—

Artificial joint operation, meniscal resection

164

1.23

0.46

1.1

—

Other diseases of hard tissues of teeth

1.33

0.46

1.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

123

1.26

0.45

1.1

—

Dermatophytosis

153

0.72

0.45

1.0

1.1

—

Unspecified fall

110

1.34

0.45

1.1

—

Alcohol dependence

1.37

0.44

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

1.37

0.44

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.37

0.44

1.1

—

Obesity and other hyperalimentation

125

1.31

0.44

1.2

1.0

—

Disorders of vestibular function (Vertigo)

102

1.35

0.43

1.1

1.0

—

Other maternal disorders predominantly related to pregnancy

0.62

0.43

1.2

1.1

—

Soft tissue disorders

131

1.22

0.42

1.0

1.1

—

Ventral hernia

1.40

0.42

1.1

1.0

—

Injuries to the ankle and foot

132

1.28

0.42

1.1

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.41

0.0

1.0

—

Benign neoplasm of breast

0.00

0.41

0.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.41

0.0

1.0

—

Lichen planus, including avohilmo

1.47

0.40

1.0

—

Dorsopathies

121

1.22

0.40

1.0

1.1

—

Type 1 diabetes

1.47

0.40

1.0

—

Other symptoms and signs involving the urinary system

0.00

0.40

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.40

0.0

1.0

—

Fracture of femur

1.32

0.39

1.3

1.1

—

Diseases of salivary glands

1.31

0.39

1.0

—

Other functional intestinal disorders

1.33

0.39

1.3

1.1

—

DVT of lower extremities

1.43

0.39

1.0

—

Cervicalgia

1.43

0.39

1.0

1.1

—

Diplopia

0.00

0.39

0.0

1.0

—

Burns and corrosions

0.00

0.39

0.0

1.0

—

Excessive attrition of teeth

106

1.32

0.39

1.1

—

Malignant neoplasm of prostate

1.40

0.39

1.0

1.1

—

malignant neoplasm of male genital organs

1.40

0.38

1.0

1.1

—

Other skin changes

1.39

0.38

1.0

—

Anxiety disorders, excluding more controls

127

1.23

0.38

1.3

1.1

—

Allergic rhinitis

1.37

0.37

1.4

1.0

—

Sciatica+with lumbago

1.31

0.37

1.1

—

Anxiety disorders

137

1.22

0.36

1.3

1.1

—

Symptoms and signs involving the urinary system

150

1.22

0.36

1.0

1.1

—

Colorectal cancer

1.43

0.35

1.3

1.0

—

Disorders of sclera, cornea, iris and ciliary body

123

0.73

0.35

1.1

1.0

—

Other and unspecified disorders of vitreous body

1.33

0.35

1.0

1.1

—

Dementia, including avohilmo

1.28

0.35

1.1

1.0

—

Artrosis, including avohilmo

113

1.21

0.34

1.0

1.1

—

Other anxiety disorders

1.38

0.34

1.4

1.0

—

Gonarthrosis, primary, with knee surgery

129

1.23

0.34

1.2

1.1

—

Other extrapyramidal and movement disorders in other diseases

1.30

0.33

1.5

1.0

—

Diaphragmatic hernia

0.69

0.33

1.2

1.0

—

Other nutritional deficiencies

137

1.24

0.32

1.2

1.0

—

Other gastritis (incl. Duodenitis)

1.28

0.32

1.0

—

Fall on and from stairs and steps

1.28

0.32

1.2

1.0

—

Triptan medication for migraine, min. 3 purchases

1.33

0.31

1.2

1.0

—

Persons encountering health services for examination and investigation

111

0.81

0.31

1.0

1.1

—

Dental pulpitis, including avohilmo

143

0.82

0.31

1.2

1.1

—

Diabetic retinopathy

1.31

0.31

1.1

—

Malignant neoplasm of prostate, including Hilmo

1.33

0.31

1.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.31

0.30

1.0

1.1

—

Obesity, other/unspecified

1.30

0.30

1.3

1.0

—

Caries of enamel

150

0.82

0.30

1.2

1.1

—

Cervical disc disorders

1.31

0.30

1.0

1.1

—

Polyp of the female genital tract

1.31

0.29

1.0

1.1

—

Diabetic retinopathy, excluding more controls

1.25

0.28

1.1

1.2

—

Neurotic, stress-related and somatoform disorders

136

1.18

0.27

1.3

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.27

0.27

1.0

—

Injuries to the shoulder and upper arm

172

1.17

0.27

1.0

1.1

—

Endometriosis

1.23

0.27

1.0

1.1

—

Inguinal hernia

123

0.81

0.27

1.2

1.1

—

Symptoms and signs involving the digestive system and abdomen

125

1.16

0.27

1.1

—

Spontaneous abortion

1.32

0.27

1.1

—

Cystitis

127

1.17

0.26

1.0

1.1

—

Primary coxarthrosis, bilateral

0.67

0.25

1.2

1.1

—

Other diseases of anus and rectum

1.25

0.25

1.1

—

Other diseases of upper respiratory tract

151

1.14

0.25

1.1

—

Disorders of vitreous body

119

1.22

0.25

1.0

1.1

—

Other disorders of lacrimal gland

1.18

0.24

1.0

1.1

—

Migraine

1.18

0.24

1.1

1.0

—

Disorders of breast

0.71

0.24

1.0

1.1

—

Disorders of synovium and tendon

101

1.21

0.22

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.25

0.22

1.0

—

Superficial injury of head

1.25

0.22

1.0

—

Alzheimer disease, excluding more controls

1.22

0.22

1.0

—

Disorders of psychological development

0.00

0.21

0.0

1.1

—

Alzheimer disease, including avohilmo

0.78

0.21

1.0

1.1

—

Normal-pressure hydrocephalus

0.00

0.21

0.0

1.0

—

Special screening examination for neoplasms

0.00

0.21

0.0

1.0

—

Other disorders of nervous system

0.00

0.21

0.0

1.0

—

Paralytic strabismus

0.00

0.21

0.0

1.0

—

Acute gastritis

0.00

0.21

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.21

0.0

1.0

—

Spirochaetal infections, other/unspecified

0.00

0.21

0.0

1.0

—

Elevated blood glucose level

0.00

0.21

0.0

1.0

—

Unspecified urinary incontinence

0.00

0.21

0.0

1.1

—

LSIL lesion of the cervix uteri

0.00

0.21

0.0

1.0

—

Conjunctivitis (acute, non atopic)

1.19

0.21

1.2

1.0

—

Cyst of kidney

0.00

0.21

0.0

1.0

—

conjunctival haemorrhage

0.00

0.21

0.0

1.0

—

Hydrocephalus

0.00

0.21

0.0

1.0

—

Other noninflammatory disorders of vagina

0.00

0.21

0.0

1.1

—

Other specified/unspecified hearing loss

0.00

0.21

0.0

1.0

—

Other and unspecified visual disturbances

0.00

0.21

0.0

1.0

—

Burns and corrosions of external body surface, specified by site

0.00

0.21

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

1.0

—

Other disorders of amniotic fluid and membranes

0.00

0.21

0.0

1.0

—

Tooth eruption problems

0.00

0.21

0.0

1.1

—

Benign neoplasms

145

0.87

0.21

1.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.21

0.0

1.0

—

Disorders of vitreous body and globe

121

1.19

0.21

1.0

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

143

1.17

0.20

1.3

1.0

—

Disorders of lacrimal system

1.23

0.20

1.0

—

Depression or dysthymia

1.16

0.20

1.0

—

Other disorders of eyelid

106

0.81

0.20

1.0

1.1

—

Fibroblastic disorders

1.22

0.20

1.0

—

Polyuria

1.20

0.19

1.0

1.1

—

Functional dyspepsia

1.20

0.19

1.2

1.1

—

Soft tissue disorders related to use, overuse and pressure

1.20

0.19

1.3

1.0

—

Hernia

167

1.12

0.19

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.18

0.19

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.19

0.19

1.1

—

External causes of morbidity and mortality

1.17

0.18

1.0

1.1

—

Other degenerative diseases of the nervous system

1.16

0.18

1.0

1.1

—

Nontoxic goitre/thyroid nodule

1.17

0.17

1.0

1.1

—

Benign paroxysmal vertigo

1.11

0.17

1.1

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

0.76

0.17

1.0

—

Temporomandibular joint disorders, including avohilmo

0.72

0.17

1.0

—

Chronic gastritis

0.72

0.16

1.0

1.1

—

Abrasion of teeth

1.18

0.16

1.1

1.0

—

Sleep disorders

141

1.13

0.16

1.2

1.1

—

Propionic acid derivatives

0.77

0.16

1.0

1.2

—

Diseases of oral cavity, salivary glands and jaws

1.16

0.16

1.0

1.1

—

Arthropathies

1.13

0.15

1.0

1.1

—

Retinal detachments and breaks

0.76

0.15

1.0

1.1

—

Insomnia

136

1.12

0.15

1.2

1.1

—

Tonsillectomy and adenotomy

1.14

0.15

1.1

—

Other diseases of lip and oral mucosa

1.20

0.15

1.2

1.0

—

Other disorders of skin and subcutaneous tissue

158

1.12

0.15

1.1

—

Peripheral artery disease

1.16

0.15

1.0

—

Cholelithiasis, broad definition with cholecystitis

152

1.11

0.14

1.0

1.1

—

Presence of cardiac and vascular implants and grafts

1.16

0.14

1.1

—

Cholelithiasis

150

1.10

0.13

1.0

1.1

—

Excessive earwax

133

0.88

0.11

1.1

—

Exposure to other specified factors

158

1.10

0.11

1.2

1.1

—

Unspecific neurodegenerative disorder

1.14

0.11

1.0

1.1

—

Transient ischemic attack

116

1.12

0.11

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

1.13

0.10

1.0

1.2

—

Dentofacial anomalies [including malocclusion]

108

1.12

0.10

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

1.08

0.09

1.0

—

Seborrhoeic keratosis

1.06

0.09

1.0

—

Dizziness and giddiness

156

0.91

0.09

1.3

1.1

—

Fracture of lower leg, including ankle

115

1.12

0.09

1.1

—

Postmenopausal bleeding

1.07

0.09

1.0

1.1

—

Striking against or struck by other objects

1.11

0.09

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.07

0.08

1.5

1.1

—

Cerebrovascular diseases

143

1.08

0.08

1.0

1.1

—

Ovarian cyst

0.78

0.08

1.0

1.1

—

Vasomotor and allergic rhinitis

1.03

0.08

1.3

1.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.10

0.08

1.0

1.2

—

Benign neoplasm: Colon, unspecified

0.83

0.08

1.0

—

Alzheimer’s disease, strict definition

0.78

0.08

1.0

1.1

—

Senile cataract

1.10

0.08

1.0

1.1

—

Obesity due to excess calories

1.14

0.08

1.3

1.0

—

Coxibs

0.81

0.08

1.0

1.2

—

Acetic acid derivatives and related substances

1.06

0.07

1.0

1.2

—

Blepharochalasis

0.86

0.07

1.0

1.1

—

Calculus of kidney and ureter

0.86

0.07

1.0

—

Keratitis

0.85

0.07

1.0

—

Internal derangement of knee

1.03

0.07

1.1

—

Neurological diseases

1.08

0.07

1.1

—

Urolithiasis

1.03

0.07

1.3

1.0

—

Any dementia

1.11

0.07

1.2

1.0

—

Degenerative diseases of the nervous system

0.86

0.07

1.0

1.1

—

Falls/tendency to fall

133

0.94

0.06

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

117

1.08

0.06

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

173

0.95

0.06

1.2

1.1

—

Psychiatric diseases

128

1.06

0.06

1.1

1.0

—

Fracture of forearm

100

1.10

0.06

1.2

1.1

—

Stroke, including SAH

129

1.07

0.05

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

110

1.09

0.05

1.0

1.1

—

Disorders of conjunctiva

145

0.94

0.04

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

148

1.05

0.04

1.2

1.1

—

Leiomyoma of uterus

0.92

0.04

1.0

1.1

—

Gastrointestinal diseases

0.91

0.04

1.0

1.1

—

Stroke, excluding SAH

124

1.06

0.04

1.0

1.1

—

Diseases of the eye and adnexa

1.06

0.03

1.0

1.1

—

Extrapyramidal and movement disorders

1.09

0.03

1.4

1.1

—

Polycystic ovarian syndrome, consortium definition

0.94

0.02

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

111

0.96

0.02

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

168

1.04

0.02

1.0

1.1

—

Abdominal and pelvic pain

125

0.96

0.02

1.1

—

Periapical abscess

1.08

0.02

1.1

—

Any dementia, excluding more controls

1.07

0.01

1.2

1.0

—

Conjunctivitis

128

1.04

0.01

1.1

—

Other symptoms and signs involving cognitive functions and awareness

115

0.95

0.01

1.2

1.1

—

Anxiety (asthma-related co-morbidities)

1.05

0.01

1.3

1.1

—

Fall on same level involving ice and snow

124

1.05

0.00

1.2

1.0

—

Inflammatory diseases of female pelvic organs

0.94

0.00

1.1

—

Other neurological diseases

154

0.97

0.00

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.03

0.00

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

144

0.97

0.00

1.2

1.1

—

Mycoses

182

1.00

0.00

1.0

1.1

—

Other intervertebral disc disorders

118

1.02

0.00

1.1

—

Chronic diseases of tonsils and adenoids

104

0.97

0.00

1.1

—

Gingivitis and periodontal diseases

139

1.00

0.00

1.0

1.1

—

Any mental disorder

141

0.99

0.00

1.0

—

Transport accidents

1.04

0.00

1.1

—

Dermatitis and eczema

180

1.00

0.00

1.1

—

All anxiety disorders

1.02

0.00

1.3

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.96

0.00

1.0

—

Pure hypercholesterolaemia

117

1.00

0.00

1.2

1.1

—

Allergic conjunctivitis

102

0.95

0.00

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.02

0.00

1.1

—

Diseases of the musculoskeletal system and connective tissue

0.95

0.00

1.0

1.1

—

Chronic periodontitis, complicated

141

0.98

0.00

1.0

1.1

—

Sequelae of cerebrovascular disease

1.05

0.00

1.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

122

0.98

0.00

1.3

1.1

—

Use of anticholinesterases

1.05

0.00

1.0

1.1

—

N06DA Anticholinesterases

1.05

0.00

1.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.0

—

Other and/or unspecified nontoxic goitre

0.00

0.0

1.0

—

Haemangioma, any site

0.00

0.0

1.0

—

Right bundle-branch block

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri

0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Excessive vomiting in pregnancy

0.00

0.0

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.0

1.0

—

Barrett oesophagus

0.00

0.0

1.0

—

Female genital prolapse

1.00

0.00

1.0

1.1

—

Viral hepatitis

0.00

-0.00

0.0

1.0

—

Haemorrhoids and perianal venous thrombosis

1.01

-0.00

1.0

1.1

—

Factors influencing health status and contact with health services

0.92

-0.00

1.0

1.1

—

Other problems related to primary support group, including family circumstances

0.00

-0.00

0.0

1.0

—

Examination and encounter for administrative purposes

0.00

-0.00

0.0

1.0

—

Preparatory care for dialysis

0.00

-0.00

0.0

1.0

—

Sulfonylureas

0.93

-0.00

1.1

—

Foreign body in alimentary tract

0.00

-0.00

0.0

1.0

—

Contusion of other and unspecified parts of foot

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Late onset)

0.84

-0.00

1.0

1.1

—

Mixed hyperlipidaemia

0.00

-0.00

0.0

1.0

—

Somnolence, stupor and coma

0.00

-0.00

0.0

1.0

—

Placenta praevia

0.00

-0.00

0.0

1.0

—

Epilepsy

0.84

-0.00

1.0

—

Vasomotor rhinitis (mode)

0.00

-0.00

0.0

1.0

—

Other reaction to severe stress, and adjustment disorders

1.00

-0.00

1.0

—

Benign neoplasm: Choroid

0.00

-0.00

0.0

1.0

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.2

—

Alzheimer disease

0.94

-0.00

1.0

1.1

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.0

—

Ocular pain

0.00

-0.00

0.0

1.0

—

Use of ropinirole

0.00

-0.00

0.0

1.0

—

Use of selegiline

0.00

-0.00

0.0

1.0

—

Poor fetal growth

0.00

-0.00

0.0

1.0

—

Polyhydramnios

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Polypectomy (DHB20)

0.00

-0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Speech and linguistic disorders

0.00

-0.00

0.0

1.1

—

Inflammatory disease of cervix uteri

0.00

-0.00

0.0

1.0

—

Prolapse and hernia of ovary and fallopian tube

0.00

-0.00

0.0

1.2

—

Noninflammatory disorders of female genital tract

0.92

-0.00

1.0

1.1

—

UC patients in KELA-register (code 208), prior to 1994

0.00

-0.00

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

-0.00

0.0

1.0

—

Dementia due to Parkinsons disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Noise effects on inner ear

0.00

-0.00

0.0

1.0

—

Other intracranial haemorrhages

0.00

-0.00

0.0

1.0

—

Abnormalities of forces of labour

0.00

-0.00

0.0

1.0

—

Chronic suppurative otitis media, including avohilmo

0.00

-0.00

0.0

1.0

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

-0.00

0.0

1.0

—

Menorrhagia

0.88

-0.00

1.0

1.1

—

Twin gestation

0.00

-0.00

0.0

1.0

—

Pleural plaque without asbestos

0.00

-0.00

0.0

1.0

—

Melanocytic naevi

0.96

-0.00

1.2

1.0

—

Crowding of teeth, including avohilmo

0.00

-0.00

0.0

1.2

—

Haemangioma and lymphangioma, any site

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Use of other anti-dementia drugs

0.94

-0.00

1.1

—

Acne

0.00

-0.00

0.0

1.1

—

Use of memantine

0.94

-0.00

1.1

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Traumatic amputation of wrist and hand

0.00

-0.00

0.0

1.0

—

Excessive, frequent and irregular menstruation

1.01

-0.00

1.0

1.1

—

Unspecified jaundice

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Legionella sp Ag [Presence] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS